New hope for mastocytosis sufferers: targeted drug shows promise in symptom control
Symptom relief
Ongoing
This study tests a drug called avapritinib in people with indolent systemic mastocytosis whose symptoms are not well controlled by current treatments. The goal is to see if the drug can reduce symptoms like flushing, fatigue, and stomach issues. About 251 adults will take part, a…
Phase: PHASE2 • Sponsor: Blueprint Medicines Corporation • Aim: Symptom relief
Last updated May 05, 2026 11:56 UTC